Blinman PL[au] - Search Results

Year	Number of Results
2012	2
2013	1
2018	4
2020	2
2021	1

1

How long is too long? A scoping review of health system delays in lung cancer.

Malalasekera A, Nahm S, Blinman PL, Kao SC, Dhillon HM, Vardy JL. Malalasekera A, et al. Among authors: blinman pl. Eur Respir Rev. 2018 Aug 29;27(149):180045. doi: 10.1183/16000617.0045-2018. Print 2018 Sep 30. Eur Respir Rev. 2018. PMID: 30158277 Free article. Review.

2

Why do delays to diagnosis and treatment of lung cancer occur? A mixed methods study of insights from Australian clinicians.

Malalasekera A, Dhillon HM, Shunmugasundaram C, Blinman PL, Kao SC, Vardy JL. Malalasekera A, et al. Among authors: blinman pl. Asia Pac J Clin Oncol. 2021 Apr;17(2):e77-e86. doi: 10.1111/ajco.13335. Epub 2020 Apr 16. Asia Pac J Clin Oncol. 2021. PMID: 32298539

3

Ibudilast for prevention of oxaliplatin-induced acute neurotoxicity: a pilot study assessing preliminary efficacy, tolerability and pharmacokinetic interactions in patients with metastatic gastrointestinal cancer.

Teng C, Reuter SE, Blinman PL, Dhillon HM, Galettis P, Proschogo N, McLachlan AJ, Vardy JL. Teng C, et al. Among authors: blinman pl. Cancer Chemother Pharmacol. 2020 Oct;86(4):547-558. doi: 10.1007/s00280-020-04143-8. Epub 2020 Sep 19. Cancer Chemother Pharmacol. 2020. PMID: 32949265 Clinical Trial.

4

Delays to diagnosis and treatment of lung cancer in Australia: healthcare professional perceptions of actual versus acceptable timeframes.

Malalasekera A, Dhillon HM, Blinman PL, Kao SC, Vardy JL. Malalasekera A, et al. Among authors: blinman pl. Intern Med J. 2018 Sep;48(9):1063-1071. doi: 10.1111/imj.13970. Intern Med J. 2018. PMID: 29756277

5

Times to Diagnosis and Treatment of Lung Cancer in New South Wales, Australia: A Multicenter, Medicare Data Linkage Study.

Malalasekera A, Blinman PL, Dhillon HM, Stefanic NA, Grimison P, Jain A, D'Souza M, Kao SC, Vardy JL. Malalasekera A, et al. Among authors: blinman pl. J Oncol Pract. 2018 Oct;14(10):e621-e630. doi: 10.1200/JOP.18.00125. Epub 2018 Sep 12. J Oncol Pract. 2018. PMID: 30207854

6

Patients' preferences for adjuvant sorafenib after resection of renal cell carcinoma in the SORCE trial: what makes it worthwhile?

Blinman PL, Davis ID, Martin A, Troon S, Sengupta S, Hovey E, Coskinas X, Kaplan R, Ritchie A, Meade A, Eisen T, Stockler MR. Blinman PL, et al. Ann Oncol. 2018 Feb 1;29(2):370-376. doi: 10.1093/annonc/mdx715. Ann Oncol. 2018. PMID: 29177440 Free article. Clinical Trial.

7

Workforce shortages in medical oncology: a looming threat to quality cancer care.

Koczwara B, Barton MB, Walpole ET, Grimison P, Blinman PL, Crossing S, Francis K. Koczwara B, et al. Among authors: blinman pl. Med J Aust. 2012 Jan 16;196(1):32-3. doi: 10.5694/mja11.10356. Med J Aust. 2012. PMID: 22256925

8

The shortage of medical oncologists: the Australian Medical Oncologist Workforce Study.

Blinman PL, Grimison P, Barton MB, Crossing S, Walpole ET, Wong N, Francis K, Koczwara B. Blinman PL, et al. Med J Aust. 2012 Jan 16;196(1):58-61. doi: 10.5694/mja11.10363. Med J Aust. 2012. PMID: 22256937

9

Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancer.

McCaughan GJ, Blinman PL, Boyer MJ, Stockler MR. McCaughan GJ, et al. Among authors: blinman pl. Intern Med J. 2013 Apr;43(4):424-9. doi: 10.1111/j.1445-5994.2012.02846.x. Intern Med J. 2013. PMID: 22647141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results